BACKGROUND: The prognoses with respect to mortality and hepatic and nonhepatic outcomes across the histologic spectrum of nonalcoholic fatty liver disease (NAFLD) are not well defined. CONCLUSIONS: In this prospective study involving patients with NAFLD, fibrosis stages F3 and F4 were associated with increased risks of liver-related complications and death.
Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.
Read the full paper
Access the original peer-reviewed research via OpenAlex.
| Category | 🧬 Medicine & Biology |
| Published | Oct 20, 2021 |
| Journal | New England Journal of Medicine |
| Authors | Arun J. Sanyal, Mark L. Van Natta, Jeanne M. Clark, Brent A. Neuschwander‐Tetri, Anna‐Mae Diehl |
| DOI | 10.1056/nejmoa2029349 |
| Citations | 1,059 |
| Source | OpenAlex |